199 related articles for article (PubMed ID: 16152713)
1. Uridine in the prevention and treatment of NRTI-related mitochondrial toxicity.
Walker UA; Venhoff N
Antivir Ther; 2005; 10 Suppl 2():M117-23. PubMed ID: 16152713
[TBL] [Abstract][Full Text] [Related]
2. Uridine abrogates mitochondrial toxicity related to nucleoside analogue reverse transcriptase inhibitors in HepG2 cells.
Walker UA; Venhoff N; Koch EC; Olschewski M; Schneider J; Setzer B
Antivir Ther; 2003 Oct; 8(5):463-70. PubMed ID: 14640394
[TBL] [Abstract][Full Text] [Related]
3. Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions.
Walker UA; Auclair M; Lebrecht D; Kornprobst M; Capeau J; Caron M
Antivir Ther; 2006; 11(1):25-34. PubMed ID: 16518957
[TBL] [Abstract][Full Text] [Related]
4. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
Lewis W
Antivir Ther; 2005; 10 Suppl 2():M13-27. PubMed ID: 16152703
[TBL] [Abstract][Full Text] [Related]
5. Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy.
Côté HC
Antivir Ther; 2005; 10 Suppl 2():M3-11. PubMed ID: 16152702
[TBL] [Abstract][Full Text] [Related]
6. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B
Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183
[TBL] [Abstract][Full Text] [Related]
7. Update on mitochondrial toxicity: where are we now?
Walker UA
J HIV Ther; 2003 May; 8(2):32-5. PubMed ID: 12838162
[TBL] [Abstract][Full Text] [Related]
8. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level.
Nolan D; Hammond E; James I; McKinnon E; Mallal S
Antivir Ther; 2003 Dec; 8(6):617-26. PubMed ID: 14760896
[TBL] [Abstract][Full Text] [Related]
9. A brief overview of mechanisms of mitochondrial toxicity from NRTIs.
Kohler JJ; Lewis W
Environ Mol Mutagen; 2007; 48(3-4):166-72. PubMed ID: 16758472
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity.
Moyle G
Clin Ther; 2000 Aug; 22(8):911-36; discussion 898. PubMed ID: 10972629
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors.
Venhoff N; Setzer B; Melkaoui K; Walker UA
Antivir Ther; 2007; 12(7):1075-85. PubMed ID: 18018766
[TBL] [Abstract][Full Text] [Related]
12. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.
Kakuda TN
Clin Ther; 2000 Jun; 22(6):685-708. PubMed ID: 10929917
[TBL] [Abstract][Full Text] [Related]
14. Effect of the substitution of one nucleoside analogue by one non-nucleoside reverse transcriptase inhibitor over mitochondrial DNA levels.
De Felipe B; Blanco A; Soriano-Sarabia N; Muñoz-Fernández MA; Genebat M; Vallejo A; Leal M
Infection; 2008 Jun; 36(3):266-70. PubMed ID: 18463785
[TBL] [Abstract][Full Text] [Related]
15. Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice.
Lebrecht D; Deveaud C; Beauvoit B; Bonnet J; Kirschner J; Walker UA
Arthritis Rheum; 2008 Jan; 58(1):318-26. PubMed ID: 18163507
[TBL] [Abstract][Full Text] [Related]
16. Rapid analysis of mitochondrial DNA depletion by fluorescence in situ hybridization and immunocytochemistry: potential strategies for HIV therapeutic monitoring.
Janes MS; Hanson BJ; Hill DM; Buller GM; Agnew JY; Sherwood SW; Cox WG; Yamagata K; Capaldi RA
J Histochem Cytochem; 2004 Aug; 52(8):1011-8. PubMed ID: 15258176
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial toxicity of nucleoside analogues in primary human lymphocytes.
Setzer B; Schlesier M; Thomas AK; Walker UA
Antivir Ther; 2005; 10(2):327-34. PubMed ID: 15865227
[TBL] [Abstract][Full Text] [Related]
18. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J
Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria.
Moyle G
Antivir Ther; 2005; 10 Suppl 2():M47-52. PubMed ID: 16152705
[TBL] [Abstract][Full Text] [Related]
20. Chronic stavudine exposure induces hepatic mitochondrial toxicity in adult Erythrocebus patas monkeys.
Gerschenson M; Nguyen VT; St Claire MC; Harbaugh SW; Harbaugh JW; Proia LA; Poirier MC
J Hum Virol; 2001; 4(6):335-42. PubMed ID: 12082400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]